Sign in
Taking people in United StatesNo phase

Studying Risk Factors for Type 2 Diabetes in Young People

Studies how blood sugar and insulin change in obese teens at risk of diabetes.

Key facts

Who runs it
George Washington University
Where
Aurora, Baltimore, Birmingham, Boston, Brooklyn, Charlotte, Cincinnati, Columbus, Garden City, Houston, Los Angeles, New York, Oklahoma City, Philadelphia, Phoenix, Shiprock, St. Petersburg, The Bronx, and Winston-Salem, United StatesSee the 20 sites
Trial code
Registry title
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Status
Recruiting
People taking part
3,600 people, planned
Started
1 Oct 2024
Expected to end
31 Jan 2028
Type of study
Observational
Record updated
7 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for overweight or obese children and teenagers at high risk of developing type 2 diabetes, who do not have diabetes yet.

Age
Girls 8-13 years, boys 9-15 years.
Sex
Girls and boys can join.
Disease stage
Overweight or obesity (BMI at or above the 85th percentile), puberty at Tanner Stage 2, 3 or 4, and a slightly raised HbA1c of 5.5-6.4% (37–46 mmol/mol).
Earlier treatment
No earlier insulin. No GLP-1 receptor agonist or weight loss medicine in the 6 weeks before joining. No metformin or other glucose-lowering medicine for another reason, such as PCOS, in the 6 weeks before joining.
Biomarker or test result
HbA1c 5.5-6.4% (37–46 mmol/mol).

Main reasons for not taking part

  • Diabetes, or HbA1c of 6.5% (48 mmol/mol) or higher
  • Known syndromic or monogenic obesity
  • Blood disorders that affect HbA1c
  • Bariatric surgery, or planning it
  • Current pregnancy or planning pregnancy

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Screening will occur to enrich the yield of individuals who are highly predisposed to develop youth-onset T2D and include those with all of the following criteria:
  • Overweight or obesity with BMI ≥85th percentile
  • Age 8-13 year for girls, 9-15 year for boys (inclusion younger for girls as puberty tends to start a year earlier in girls)
  • Tanner Stage 2, 3, or 4
  • Elevated HbA1c 5.5-6.4%

Who cannot take part

  • Prior treatment with insulin
  • Use of glucagon-like peptide-1 (GLP-1) receptor agonist or any weight loss medications in the 6 weeks prior to enrollment
  • Planning treatment with glucagon-like peptide-1 (GLP-1) receptor agonist or any weight loss medications
  • Conditions predisposing to diabetes or altering the trajectory of puberty
  • Major systemic organ disease
  • History of bariatric surgery or currently planning bariatric surgery
  • Diabetes based on history, or HbA1c ≥6.5% in the medical record or at screening
  • Medications affecting glucose dynamics during the screening and enrollment period
  • Use of metformin or any glucose lowering medication for a reason other than treatment of diabetes (e.g., for PCOS) in the 6 weeks prior to enrollment
  • Planning treatment with metformin or any glucose lowering medication or planning to use such medications for a reason other than treatment of diabetes (e.g., for PCOS)
  • Blood disorders impacting HbA1c (e.g., anemia, hemoglobin variants)
  • An individual who meets any of the following criteria will be excluded from participation:
  • Unable/unwilling to provide consent/participate fully
  • Known syndromic/monogenic obesity
  • Current pregnancy or currently planning pregnancy
  • Use of GnRH agonist, estrogen, or testosterone
  • Individuals who do not speak English or Spanish, given validation of the questionnaires to be utilized

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 15 years old?

Where in United States

  • Children's Hospital ColoradoAurora, United StatesContact: Kelly WiitalaTaking people
  • Johns Hopkins University School Of MedicineBaltimore, United StatesContact: Benjamin PottsTaking people
  • University of Alabama at BirminghamBirmingham, United StatesContact: Laura Lee GoreeTaking people
  • Boston Children's/Joslin Diabetes Center/Massachusetts General HospitalBoston, United StatesContact: Jackson TuTaking people
  • NYU Langone Health - BrooklynBrooklyn, United StatesContact: Celia EngelsonTaking people
  • Atrium HealthCharlotte, United StatesContact: Merischia GriffinTaking people
  • Cincinnati Children's HospitalCincinnati, United StatesContact: Hailey EisenmannTaking people
  • Nationwide Children's HospitalColumbus, United StatesContact: Jacqueline BritoTaking people
  • NYU Langone Health- Long IslandGarden City, United StatesContact: Marilyn RichardsonTaking people
  • Baylor College of Medicine / Texas Children'sHouston, United StatesContact: Jesus CazaresTaking people
  • Children's Hospital Los AngelesLos Angeles, United StatesContact: Leticia EufracioTaking people
  • NYU Langone Health ManhattanNew York, United StatesContact: Laura MarchTaking people
  • The University of Oklahoma Health Sciences CenterOklahoma City, United StatesContact: Jeff PreskeTaking people
  • Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Sarah LoughranTaking people
  • Arizona State UniversityPhoenix, United StatesContact: Irene MarquezTaking people
  • Phoenix Children'sPhoenix, United StatesContact: Lynette B DavisTaking people
  • Colorado Navajo NationShiprock, United StatesContact: Melanie AspaasTaking people
  • Johns Hopkins All Children's HospitalSt. Petersburg, United StatesContact: Antonika FordTaking people
  • Albert Einstein College of MedicineThe Bronx, United StatesContact: Nicole MaysonetTaking people
  • Wake Forest UniversityWinston-Salem, United StatesContact: Alisha DavisTaking people

About the trial

What the trial wants to find out

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Plain-language title
Studying Risk Factors for Type 2 Diabetes in Young PeopleGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06525259, who can take part
Record updated
7 May 2026